Dr. Kojouri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
307 S 13th St
Mount Vernon, WA 98274Phone+1 360-814-2146Fax+1 360-814-2445
Education & Training
University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 2004 - 2006- University of Oklahoma Health Sciences CenterResidency, Internal Medicine, 2001 - 2004
Tehran University of Medical Sciences School of MedicineClass of 1991
Certifications & Licensure
WA State Medical License 2009 - 2025
OK State Medical License 2003 - 2010
Clinical Trials
- Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer Start of enrollment: 2008 Apr 23
- Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients Start of enrollment: 2013 Jul 19
- Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm Start of enrollment: 2014 Jun 01
Publications & Presentations
PubMed
- 455 citationsSplenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and ...Kiarash Kojouri, Sara K. Vesely, Deirdra R. Terrell, James N. George
Blood. 2004-11-01 - 74 citationsThrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study.Koushan Siami, Kiarash Kojouri, Karen K. Swisher, George B. Selby, James N. George
Transplantation. 2008-01-15 - 92 citationsQuinine-Associated Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome: Frequency, Clinical Features, and Long-Term OutcomesKiarash Kojouri, Sara K. Vesely, James N. George
Annals of Internal Medicine. 2001-12-18
Lectures
- Limitations to Receiving Allogeneic Hematopoietic Cell Transplantation for Treatment of Acute Myeloid Leukemia: A Large Multi-Center Prospective Longitudinal Observati...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Survival Differences Among Patients (pts) with Acute Myeloid Leukemia (AML) Treated with Allogeneic Hematopoietic Cell Transplantation (HCT) Versus Non-HCT Therapies: ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
